Tanweera Shaheena Khan

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

Glimelius, Bengt; Khan, Tanweera Shaheena; Adolfsson, Karin; Angenete, Eva et al.

Ingår i eClinicalMedicine, 2024

• DOI för Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)
• Ladda ner fulltext (pdf) av Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Fröss-Baron, Katarzyna; Garske, Ulrike; Welin, Staffan; Granberg, Dan et al.

Ingår i Neuroendocrinology, s. 330-343, 2021

• DOI för 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants
• Ladda ner fulltext (pdf) av 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Sandström, Mattias; Freedman, Nanette; Fröss-Baron, Katarzyna; Khan, Tanweera et al.

Ingår i EJNMMI Physics, 2020

• DOI för Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
• Ladda ner fulltext (pdf) av Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving ¹⁷⁷Lu-DOTATATE therapy

Sandström, Mattias; Fröss-Baron, Katarzyna; Khan, Tanweera Shaheena; Granberg, Dan et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving ¹⁷⁷Lu-DOTATATE therapy

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Garske, Ulrike; Sandström, Mattias; Fröss-Baron, Katarzyna; Lundin, Lars et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 970-988, 2018

• DOI för Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
• Ladda ner fulltext (pdf) av Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

Glimelius, Bengt; Khan, Tanweera Shaheena; Adolfsson, Karin; Angenete, Eva et al.

Ingår i eClinicalMedicine, 2024

• DOI för Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)
• Ladda ner fulltext (pdf) av Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Fröss-Baron, Katarzyna; Garske, Ulrike; Welin, Staffan; Granberg, Dan et al.

Ingår i Neuroendocrinology, s. 330-343, 2021

• DOI för 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants
• Ladda ner fulltext (pdf) av 177Lu-DOTATATE Therapy of Advanced Pancreatic Neuroendocrine Tumors Heavily Pretreated With Chemotherapy: Analysis of Outcome, Safety and Their Determinants

Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Sandström, Mattias; Freedman, Nanette; Fröss-Baron, Katarzyna; Khan, Tanweera et al.

Ingår i EJNMMI Physics, 2020

• DOI för Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points
• Ladda ner fulltext (pdf) av Kidney dosimetry in 777 patients during ¹⁷⁷Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving ¹⁷⁷Lu-DOTATATE therapy

Sandström, Mattias; Fröss-Baron, Katarzyna; Khan, Tanweera Shaheena; Granberg, Dan et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2018

• DOI för Absorbed doses based on a single measurement point versus three measurement points in 600 patients with neuroendocrine tumours receiving ¹⁷⁷Lu-DOTATATE therapy

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Garske, Ulrike; Sandström, Mattias; Fröss-Baron, Katarzyna; Lundin, Lars et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 970-988, 2018

• DOI för Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
• Ladda ner fulltext (pdf) av Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

One pot preparation of Ga-68-labelled macroaggregated albumin for PET-imaging of acute pulmonary embolism and myocardial perfusion quantification

Velikyan, Irina; Berhane, T.; Khan, Tanweera Shaheena; Borges, João Batista et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, 2012

Vincristine, Cisplatin, Teniposide and Cyclophosphamide Combination in the Treatment of Recurrent or Metastatic Adrenocortical Cancer

Khan, Tanweera Shaheena; Sundin, Anders; Juhlin, Claes; Wilander, Erik et al.

Ingår i Medical Oncology, s. 167-177, 2004

• DOI för Vincristine, Cisplatin, Teniposide and Cyclophosphamide Combination in the Treatment of Recurrent or Metastatic Adrenocortical Cancer

11C-metomidate PET imaging of adrenocortical cancer

Khan, Tanweera Shaheena; Sundin, Anders; Juhlin, Claes; Långström, Bengt et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 403-410, 2003

Labelling of octreotide using Br-76-prosthetic groups

Yngve, Ulrika; Khan, Tanweera Shaheena; Bergström, Mats; Långstrom, Bengt

Ingår i Journal of labelled compounds & radiopharmaceuticals, s. 561-573, 2001

• DOI för Labelling of octreotide using Br-76-prosthetic groups

Streptozocin and o,p'DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use

Khan, Tanweera Shaheena; Imam, Hassan; Juhlin, Claes; Skogseid, Britt et al.

Ingår i Annals of Oncology, s. 1281-1287, 2000

PET with [¹¹C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions

Bergström, Mats; Sörensen, Jens; Khan, Tanweera Shaheena; Juhlin, Claes et al.

Ingår i Clinical Positron Imaging, s. 339, 1999

• DOI för PET with [¹¹C]-Metomidate for the Visualization of Adrenocortical Tumors and Discrimination from Other Lesions

New Diagnostic and Therapeutic Approaches in Adrenocortical Cancer

Khan, Tanweera Shaheena

2004

• Ladda ner fulltext (pdf) av New Diagnostic and Therapeutic Approaches in Adrenocortical Cancer

Expression of c-Kit, phospho-c-kit, PDGFRβ and absence of c-Kit mutation in exon 11 in adrenocortical cancer

Khan, Tanweera Shaheena; Gobl, Anders; Imam, Hassan; Juhlin, Claes et al.

Quality of life and late toxicity after total neoadjuvant treatment for locally advanced rectal cancer – LARCT-US

Imam, Israa; Khan, Tanweera Shaheena; Nilsson, Per J; Glimelius, Bengt